Researchers Identified Metabolite That Reduces Plaque
A study found that pentadecanoic acid successfully lowered atherosclerotic plaque burden in mouse models.
Updated on Oct. 7, 2026 in Heart Disease
Live Poll
Does new research on gut bacteria make you more optimistic about future medical treatments?
Scientists have identified pentadecanoic acid as a key metabolite that helps alleviate atherosclerosis. This saturated fatty acid produced by gut bacteria was found to suppress cholesterol production.
Why it matters
The findings reveal a potential biological mechanism for managing heart health through the regulation of gut bacterial metabolites. This research highlights how specific fatty acids influence cholesterol pathways in the liver.
Researchers analyzed 100 gut bacterial strains to isolate the compound. The study demonstrated that pentadecanoic acid reduces plaque burden by 50% in mice through the inhibition of HMG-CoA reductase.
The players
Bacteroides uniformis
This gut bacterial strain was administered in the study to demonstrate its role in alleviating atherosclerosis.
The details
Pentadecanoic acid, a saturated odd-chain fatty acid produced by various Bacteroidota genera, acts by suppressing hepatic cholesterol biosynthesis. The study also determined that this metabolite promotes the removal of low-density lipoprotein cholesterol while upregulating hepatic receptor expression.
Timeline
October 7, 2026: The research findings were published in a scientific article.
The Big Picture
This study follows the path set by the human microbiome-metabolite research initiative by linking specific gut-derived compounds to chronic disease outcomes. It demonstrates that gut flora composition significantly influences systemic lipid metabolism.
While this discovery offers insight into cholesterol regulation, it does not currently change existing medical treatments for patients with dyslipidaemia. Further human trials are necessary to determine if pentadecanoic acid could eventually serve as a dietary or therapeutic intervention.
The takeaway
This study provides a new theoretical framework for how gut bacteria influence heart disease through specific metabolic pathways. It suggests that future cardiovascular health research will likely focus more heavily on the role of individual bioactive metabolites.
Further reading
For more information on the evolving understanding of cardiovascular health, visit the Heart Disease section.
More information
Read the full details of the scientific research study published in Nature.
Live Poll
Does new research on gut bacteria make you more optimistic about future medical treatments?
